Picture of ChoA Pharmaceutical Co logo

034940 ChoA Pharmaceutical Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Annual cashflow statement for ChoA Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1,122-1,606-8,043515-11,133
Depreciation
Amortisation
Non-Cash Items4,1683,4944,6411,8407,618
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,700-3,016-973-6,187-347
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities4,1571,922-1,480-1,443-1,475
Capital Expenditures-1,662-3,641-3,864-2,922-943
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-709-3961,9981,3691,674
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2,371-4,037-1,866-1,553731
Financing Cash Flow Items-202-16810111.5-27.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,092-3,8324,8251,807-1,690
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-100-5,8731,585-1,223-2,478